Y Biologics Inc (338840)

Currency in KRW
9,980
-250(-2.44%)
Closed·
338840 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,51010,310
52 wk Range
7,23038,000
Key Statistics
Bid/Ask
9,980.00 / 10,020.00
Prev. Close
10,230
Open
10,080
Day's Range
9,510-10,310
52 wk Range
7,230-38,000
Volume
48.15K
Average Volume (3m)
113.7K
1-Year Change
-11.2889%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
338840 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-284.00 / --
Revenue / Forecast
281.89M / --
EPS Revisions
Last 90 days

338840 Income Statement

Compare 338840 to Peers and Sector

Metrics to compare
338840
Peers
Sector
Relationship
P/E Ratio
−3.4x−5.1x−0.4x
PEG Ratio
0.01−0.180.00
Price/Book
6.8x1.4x2.6x
Price / LTM Sales
55.0x9.1x3.0x
Upside (Analyst Target)
-21.6%48.7%
Fair Value Upside
Unlock19.1%5.6%Unlock

Y-Biologics, Inc., an antibody therapeutics development company, engages in the research and development of immuno-oncology drugs and antibody drugs. The company develops YBL-006, a PD-1 immune-oncology agent that is phase 1 clinical stage for the treatment of solid tumor. It also develops immunoregulatory monoclonal antibodies, such as YBL-011 and AR062 for the treatment of solid cancers; AR166, AR169, and AR170 for solid cancers; and AR153, a pH-dependent antibody for the treatment of solid cancer. Y-Biologics, Inc. was incorporated in 2007 and is headquartered in Daejeon, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
1.06M6.88%10.64B
Public Companies & Retail Investors
14.31M93.12%143.95B
Total
15.37M100.00%154.59B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
DAYLI Partners Co., Ltd.3.28%504,4275,074,536
DAYLI Empowering Biohealthcare Fund 12.38%365,5393,677,322

FAQ

What Is the Y Biologics (338840) Stock Price Today?

The Y Biologics stock price today is 9,980 KRW.

What Stock Exchange Does Y Biologics Trade On?

Y Biologics is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Y Biologics?

The stock symbol for Y Biologics is "338840."

What Is the Y Biologics Market Cap?

As of today, Y Biologics market cap is 153.36B KRW.

What Is Y Biologics's Earnings Per Share (TTM)?

The Y Biologics EPS (TTM) is -2,967.

From a Technical Analysis Perspective, Is 338840 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Y Biologics Stock Split?

Y Biologics has split 0 times.

What is the current trading status of Y Biologics (338840)?

As of Aug 08, 2026, Y Biologics (338840) is trading at a price of 9,980 KRW, with a previous close of 10,230 KRW. The stock has fluctuated within a day range of 9,510 KRW to 10,310 KRW, while its 52-week range spans from 7,230 KRW to 38,000 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.